Cargando…
Subserous invasion of VEGF-C-producing cancer cells is a possible risk factor for ileal ulceration in the non-metastatic mucosal layer during bevacizumab-combined chemotherapy for recurrent ovarian cancer: A case report
A 65-year-old woman received chemotherapy using taxane and carboplatin prior and following optimal debulking surgery for ovarian cancer stage IV. Five months later, intra-abdominal recurrence was diagnosed, and second-line chemotherapy using nogitecan and bevacizumab was administered. After five cou...
Autores principales: | Matsumoto, Takeo, Mizumoto, Yasunari, Nakade, Kyohei, Obata, Takeshi, Matsuoka, Ayumi, Myojo, Subaru, Ono, Masanori, Nakamura, Mitsuhiro, Fujiwara, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700280/ https://www.ncbi.nlm.nih.gov/pubmed/29181171 http://dx.doi.org/10.3892/mco.2017.1403 |
Ejemplares similares
-
A direct endoscopic approach for left-sided infrarenal para-aortic lymphadenectomy immediately after hysterectomy for endometrial cancer treatment: left dome formation (LDF)
por: Mizumoto, Yasunari, et al.
Publicado: (2019) -
Novel strategy of ovarian cancer implantation: Pre‐invasive growth of fibrin‐anchored cells with neovascularization
por: Matsuoka, Ayumi, et al.
Publicado: (2019) -
Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study
por: Kayahashi, Kayo, et al.
Publicado: (2021) -
Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women
por: Yamazaki, Rena, et al.
Publicado: (2015) -
Dual expression of immunoreactive estrogen receptor β and p53 is a potential predictor of regional lymph node metastasis and postoperative recurrence in endometrial endometrioid carcinoma
por: Obata, Takeshi, et al.
Publicado: (2017)